Category: Policy

Oregon’s and Compass’s Opposite Approaches to Psilocybin Therapy Should Coexist, Says Initiator of Measure 109

Marcelo Leite, Ph.D., summarizes how the medicalization and legalization regulatory models for psilocybin-assisted therapy can...

Jasmine Virdi interviews Martha Hartney, an attorney fighting for the legal use of aya-huasca as...

Not-for-profit organizations, like MAPS and Usona Institute, are just a few years away from completing...

This article introduces the Hablemos del Hikuri peyote conservation project that began in 2017 to...

The Supreme Court’s December 2020 ruling in Tanzin v. Tanvir has several lessons for psychedelic...

DECEMBER 8, 2020, COLOTLÁN, JALISCO. TO WHOM IT MAY CONCERN The Wixárika Regional Council for...

In the 2020 election, we have witnessed major drug policy reform happen in states like...

This article talks about the prevalence of psychedelic exceptionalism in activism groups, the need to...

A Critique of the DEA’s Authority over the Ceremonial Use of Controlled Substances The plaintiffs’...

Public initiative or legislative action? Attorney Gary Smith explores legal paths for psychedelics, using cannabis...